BINDU SIMON: Open Payments
NPI 1396266136 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$229 in 5 payments from 4 companies in 2025. Trend: 2023 $810 · 2024 $648 · 2025 $229
Food & beverage: $229
| Company | Payments | Amount |
|---|---|---|
| IDORSIA PHARMACEUTICALS US INC | 1 | $120 |
| Otsuka America Pharmaceutical, Inc. | 2 | $56 |
| Amgen Inc. | 1 | $30 |
| BTG International Inc. | 1 | $22 |
Products named: Tryvio, JYNARQUE, TAVNEOS, VORAXAZE.
Industry payments across TX — which companies pay providers there.
